Form 4: Elevance Health Executive Sells Shares for Tax Obligation

Elevance Health's EVP & Chief Legal Officer, Erin M. Wessling, disposed of 152 shares of common stock to cover tax liabilities related to restricted stock vesting.

Summary

• Erin M. Wessling, the Executive Vice President and Chief Legal Officer of Elevance Health, Inc. (ELV), reported a disposition of 152 shares of common stock.
• The transaction occurred on September 3, 2025, with the shares disposed of at a price of $321.59 per share.
• This disposition was specifically for the payment of tax liability incident to the vesting of previously granted restricted stock.
• Following this transaction, Ms. Wessling beneficially owns 5,020 shares of Elevance Health common stock.

Sentiment

Score: 5

Explanation: This is a routine, non-discretionary transaction for tax purposes, not indicative of positive or negative sentiment towards the company's future performance or the executive's long-term view of the stock.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Minimal direct impact on shareholders as this is a routine, non-discretionary transaction for tax purposes and does not reflect a change in the company's fundamentals or the executive's investment thesis.

Key Dates

Recommendation

The reported transaction is a routine disposition of shares to cover tax obligations upon the vesting of previously granted restricted stock. This is a common, non-discretionary event for executives and does not reflect a change in the company's fundamentals or the executive's long-term view of the stock. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

Elevance Health, ELV, Erin Wessling, Form 4, insider transaction, stock sale, restricted stock, tax withholding